Delta Lloyd’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-28,964
Closed -$2.31M 660
2016
Q3
$2.31M Buy
28,964
+4,864
+20% +$393K 0.07% 218
2016
Q2
$1.88M Hold
24,100
0.06% 231
2016
Q1
$1.33M Sell
24,100
-1,273
-5% -$69.4K 0.04% 299
2015
Q4
$1.57M Buy
25,373
+5,340
+27% +$337K 0.05% 253
2015
Q3
$1.26M Hold
20,033
0.04% 298
2015
Q2
$1.46M Buy
20,033
+6,287
+46% +$454K 0.05% 282
2015
Q1
$899K Sell
13,746
-390
-3% -$25.9K 0.03% 321
2014
Q4
$919K Buy
14,136
+2,921
+26% +$188K 0.03% 315
2014
Q3
$674K Hold
11,215
0.01% 342
2014
Q2
$777K Hold
11,215
0.02% 297
2014
Q1
$733K Buy
11,215
+2,314
+26% +$151K 0.02% 284
2013
Q4
$551K Buy
8,901
+1,869
+27% +$108K 0.02% 322
2013
Q3
$377K Buy
7,032
+873
+14% +$45K 0.01% 392
2013
Q2
$281K Buy
+6,159
New +$267K 0.01% 452

Other funds holding STJ

Delta Lloyd's STJ Position: Q4 2016 in Review

Delta Lloyd sold out of St Jude Medical (STJ) in Q4 2016, closing a stake of 28,964 shares — an estimated $2.31M sold.

Delta Lloyd first reported a position in STJ in Q2 2013 and held it in 14 quarters. The position peaked at $2.31M in Q3 2016. 551 funds tracked by Wall St. Rank hold STJ as of Q4 2016.

  • Delta Lloyd reported no remaining St Jude Medical position as of Q4 2016 after selling out during the quarter.
  • Delta Lloyd sold 28,964 St Jude Medical shares in Q4 2016, an estimated $2.31M.
  • Delta Lloyd first reported a position in St Jude Medical in Q2 2013 and held it in 14 quarters.
  • Delta Lloyd's St Jude Medical position peaked at $2.31M in Q3 2016.
  • 551 funds tracked by Wall St. Rank held St Jude Medical as of Q4 2016.

Based on Delta Lloyd's 13F filing for Q4 2016, filed 2 Feb 2017.